Report cover image

North America Point-Of-Care-Testing (POCT) Market

Publisher Data Bridge Market Research
Published Dec 01, 2025
Length 350 Pages
SKU # DAABD21133561

Description

North America Point-of-Care Testing (POCT) Market is expected to reach USD 52.47 billion by 2033 from USD 25.20 billion in 2025, growing at a CAGR of 9.6% in the forecast period of 2026 to 2033.

Market Segmentation:
North America Point-of-Care Testing (POCT) Market, By Product Type (Glucose Monitoring Products, Infectious Disease Testing Products, Cardiometabolic Monitoring Products, Pregnancy And Fertility Testing Products, Hematology Testing Products, Coagulation Monitoring Products, Drugs-Of-Abuse (DOA) Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Tumor/Cancer Marker Testing Products, Fecal Occult Testing Products, And Others), By Platform (Lateral Flow Assays/Immunochromatography Tests, Immunoassays, Dipsticks, Molecular Diagnostics, Clinical Chemistry Assays, Microfluidics, Hematology, And Others), By Application (Blood Glucose, Infectious Diseases, Vital Sign Monitoring, Cardiac Monitoring, Coagulation, Haematology, Non- Invasive Spo2 Monitoring, Blood Transfusion, Non- Invasive PCO2 Monitoring, Whole Blood Analysis, And Others), By Prescription Mode ( OTC Testing And Prescription-Based Testing), By End User ( Hospitals, Home Care, Clinics, Laboratories, Diagnostic Centers, Pathology Labs, Ambulatory Surgery Centers, Elderly Care Centers, And Others), By Distribution Channel (Direct Tender, Retail Sales, Online Sales, And Others), Country (U.S., Canada, Mexico) – Industry Overview and Forecast to 2033.


Overview of North America Point-of-Care Testing (POCT) Market Dynamics:

Driver

• Rising Use of POC Testing in Healthcare Facilities
• Rising Incidence of Substance Abuse
• Increased Adoption of Telemedicine
• Advancements Technologies Enhancing POC Testing with Biosensors and Mobile Integration
Restrain

• Data Security and Privacy Concerns
• Lack of Accuracy and Technical Challenges

Opportunity

• Rising Awareness and Advocacy for Point-Of-Care Testing
• Strategic Initiation and Decision Taken by the Market Players
• Expanding Product Range for Point-Of-Care Testing
Market Players:

The key market players operating in the North America Point-of-Care Testing (POCT) Market are listed below:

• F. HOFFMANN-LA ROCHE LTD (Switzerland),
• ABBOTT LABORATORIES (United States),
• DANAHER CORPORATION (United States),
• SIEMENS HEALTHINEERS AG (Germany),
• BD (BECTON, DICKINSON AND COMPANY) (United States),
• ACCUBIOTECH CO., LTD. (China),
• ABAXIS (A PART OF ZOETIS) (United States),
• BINX HEALTH (United States),
• BIOMERIEUX (France),
• BIO-RAD LABORATORIES, INC. (United States),
• TRINITY BIOTECH (Ireland),
• TRIVIDIA HEALTH, INC. (United States),
• THERMO FISHER SCIENTIFIC INC. (United States),
• WERFEN (Spain),
• SINOCARE INC. (China),
• GUANGZHOU WONDFO BIOTECH CO., LTD. (China),
• GETEIN BIOTECH, INC. (China),
• SNIBE (SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.) (China),
• XIAMEN BOSON BIOTECH CO., LTD. (China),
• CHEMBIO DIAGNOSTICS, INC. (United States),
• EKF DIAGNOSTICS HOLDINGS PLC (United Kingdom),
• HOLOGIC, INC. (United States),
• LAMDAGEN CORPORATION (United States),
• MERIDIAN BIOSCIENCE, INC. (United States),
• NOVA BIOMEDICAL (United States),
• PFIZER INC. (United States),
• PTS DIAGNOSTICS (United States),
• QIAGEN (Germany),
• QUIDELORTHO CORPORATION (United States),
• QUANTUMDX GROUP LTD. (United Kingdom),
• SEKISUI DIAGNOSTICS (United States),
• SIENCO, INC. (United States),
• SYSMEX CORPORATION (Japan)

Table of Contents

350 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Point-of-care-testing (Poct) Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Multivariate Modelling
2.6 Type Lifeline Curve
2.7 Primary Interviews With Key Opinion Leaders
2.8 Dbmr Market Position Grid
2.9 Market End User Coverage Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Porter’s Five Forces
4.2 Pestel Analysis
4.3 Healthcare Economy
4.3.1 Healthcare Expenditure
4.3.2 Capital Expenditure
4.3.3 Capex Trends
4.3.4 Capex Allocation
4.3.5 Funding Sources
4.3.6 Industry Benchmarks
4.3.7 Gdp Ratio In Overall Gdp
4.3.8 Healthcare System Structure
4.3.9 Government Policies
4.3.10 Economic Development
4.4 Reimbursement Framework
4.5 Opportunity Map Analysis
4.6 Value Chain Analysis
4.7 Micro And Macro Economic Factors
4.7.1 Current Market Penetration
4.7.2 Growth Prospects
4.7.3 Key Pricing Strategies
4.8 Technology Roadmap: North America Point Of Care Testing
5 North America Point-of-care Testing (Poct) Market: Regulations
6 Market Overview
6.1 Drivers
6.1.1 Rising Use Of Poc Testing In Healthcare Facilities
6.1.2 Rising Incidence Of Substance Abuse
6.1.3 Increased Adoption Of Telemedicine
6.1.4 Advancements Technologies Enhancing Poc Testing With Biosensors And Mobile Integration
6.2 Restraints
6.2.1 Data Security And Privacy Concerns
6.2.2 Lack Of Accuracy And Technical Challenges
6.3 Opportunities
6.3.1 Rising Awareness And Advocacy For Point-of-care Testing
6.3.2 Strategic Initiation And Decision Taken By The Market Players
6.3.3 Expanding Product Range For Point-of-care Testing
6.4 Challenges
6.4.1 Limited Awareness And Acceptance
6.4.2 Impact Of High Maintenance Costs Threatening Point-of-care Testing (Poct) Sustainability In Low-resource Settings
7 North America Point-of-care Testing (Poct) Market, By Product Type
7.1 Overview
7.2 Glucose Monitoring Products
7.2.1 Self-monitoring Of Blood Glucose (Smbg) Devices
7.2.1.1 Strips
7.2.1.2 Meters
7.2.1.3 Lancets And Lancing Devices
7.2.2 Continuous Glucose Monitoring (Cgm) Systems
7.3 Infectious Disease Testing Products
7.3.1 Covid-19
7.3.2 Hiv Testing Products
7.3.2.1 Testing Reagents
7.3.2.2 Testing Equipment
7.3.3 Respiratory Infection Testing Products
7.3.4 Sexually Transmitted Diseases (Std) Testing
7.3.4.1 Naat-based Systems
7.3.4.2 Non–naat-based Systems
7.3.5 Hepatitis C Testing Products
7.3.5.1 Hcv Antibody Tests
7.3.5.2 Hcv Viral Load Tests
7.3.6 Influenza Testing Products
7.3.6.1 Traditional Diagnostic Test
7.3.6.2 Molecular Diagnostic Assay
7.3.6.2.1 Rapid Influenza Diagnostic Test (Ridt)
7.3.6.2.2 Direct Fluorescent Antibody Test (Dfat)
7.3.6.2.3 Viral Culture
7.3.6.2.4 Serological Assay
7.3.6.3 Rt-pcr
7.3.6.4 Loop-mediated Isothermal Amplification-based Assay (Lamp)
7.3.6.5 Nucleic Acid Sequence-based Amplification Test (Nasbat)
7.3.6.6 Simple Amplification-based Assay (Samba)
7.3.6.7 Healthcare Associated Infection (Hai) Testing
7.3.6.8 Tropical Disease Testing Products
7.3.6.9 Other Infectious Disease Testing Products
7.4 Cardiometabolic Monitoring Products
7.4.1 Cardiac Marker Testing Products
7.4.1.1 Hstnl
7.4.1.2 Bnp
7.4.1.3 D-dimer
7.4.1.4 Ck-mb
7.4.1.5 Myoglobin
7.4.2 Blood Gas/Electrolyte Testing Products
7.4.2.1 Blood Gas/Electrolyte Testing Consumables
7.4.2.2 Blood Gas/Electrolyte Testing Instruments
7.4.3 Cartridges
7.4.4 Reagents
7.4.4.1 Portable
7.4.4.2 Benchtop
7.4.4.3 Combined Analyzers
7.4.4.4 Blood Gas Analyzers
7.4.4.5 Electrolyte Analyzers
7.4.4.6 Combined Analyzers
7.4.4.7 Blood Gas Analyzers
7.4.4.8 Electrolyte Analyzers
7.4.5 Hba1c Testing Products
7.4.5.1 Hba1c Testing Instruments
7.4.5.2 Hba1c Testing Consumables
7.4.5.3 Poc Analyzer
7.4.5.4 Ecg Device
7.4.5.5 Resting Ecg Devices
7.4.5.6 Stress Ecg Devices
7.4.5.7 Holter Monitors
7.5 Pregnancy And Fertility Testing Products
7.5.1 Pregnancy Testing Products
7.5.1.1 Strips/ Dip Sticks And Cards
7.5.1.2 Mid Stream Devices
7.5.1.3 Cassettes
7.5.1.4 Digital Devices
7.5.1.5 Line-indicator Devices
7.5.2 Fertility Testing Products
7.5.2.1 Luteinizing Hormone (Lh) Urine Test
7.5.2.2 Fsh Test
7.5.2.3 Others
7.6 Haematology Testing Products
7.7 Coagulation Monitoring Products
7.7.1 Anticoagulation Monitoring Devices
7.7.1.1 Prothrombin Time/International Normalized Ratio (Pt-inr) Testing Devices
7.7.1.2 Activated Clotting Time (Act)
7.7.1.3 Activated Partial Thromboplastin Time (Appt)
7.7.1.4 Platelet Function Monitoring Devices
7.7.1.5 Viscoelastic Coagulation Monitoring Devices
7.7.1.6 Rotational Thromboelastometry (Rotem)
7.7.1.7 Thromboelastography (Teg)
7.7.1.8 Drug-of-abuse (Doa) Testing Products
7.7.2 Doa Analysers
7.7.2.1 Immunoassays
7.7.2.2 Chromatographic Devices
7.7.2.3 Breath Analysers
7.7.3 Rapid Testing Devices
7.7.3.1 Urine Testing Devices
7.7.3.2 Oral Fluid Testing Devices
7.7.3.4 Others
7.8 Urinalysis Testing Products
7.8.1.1 Poc Urine Strip Self-testing
7.8.1.2 Poc Urine Test Strip Professional Testing
7.9 Cholesterol Testing Products
7.9.1.1 Testing Kits
7.9.1.2 Instruments
7.9.1.3 Table-top Analyzers
7.9.1.4 Hand-held Analyzers
7.10 Tumor/Cancer Marker Testing Products
7.11 Fecal Occult Testing Products
7.11.1.1 Guaiac Fob Stool Test
7.11.1.2 Lateral Flow Immuno-fob Test
7.11.1.3 Immuno-fob Agglutination Test
7.11.1.4 Immuno-fob Elisa Test
7.12 Others
8 North America Point-of-care Testing (Poct) Market, By Platform
8.1 Overview
8.2 Lateral Flow Assays/Immunochromatography Tests
8.3 Immunoassays
8.4 Dipsticks
8.5 Molecular Diagnostics
8.6 Clinical Chemistry Assays
8.7 Microfluidics
8.8 Hematology
8.9 Others
9 North America Point-of-care-testing (Poct) Market, By Application
9.1 Overview
9.2 Blood Glucose
9.3 Infectious Diseases
9.3.1 Covid-19 Testing
9.3.2 Hiv Testing
9.3.3 Hepatitis C Testing
9.3.4 Influenza Testing
9.3.5 Tuberculosis Testing
9.3.6 Others
9.4 Vital Sign Monitoring
9.5 Cardiac Monitoring
9.6 Coagulation
9.7 Haematology
9.8 Non- Invasive Spo2 Monitoring
9.9 Blood Transfusion
9.10 Non- Invasive Pco2 Monitoring
9.11 Whole Blood Analysis
9.12 Others
10 North America Point-of-care Testing (Poct) Market, By Prescription Mode
10.1 Overview
10.2 Otc Testing
10.3 Prescription-based Testing
11 North America Point-of-care-testing (Poct) Market, By Distribution Channel
11.1 Overview
11.2 Direct Tender
11.3 Retail Sales
11.4 Online Sales
11.5 Others
12 North America Point-of-care Testing (Poct) Market, By End User
12.1 Overview
12.2 Hospitals
12.2.1 Private
12.2.1.1 Tier 1
12.2.1.2 Tier 2
12.2.1.3 Tier 3
12.2.2 Public
12.2.2.1 Tier 1
12.2.2.2 Tier 2
12.2.2.3 Tier 3
12.3 Home Care
12.4 Clinics
12.5 Laboratories
12.6 Diagnostic Centers
12.7 Pathology Labs
12.8 Ambulatory Surgery Centers
12.9 Elderly Care Centers
12.10 Others
13 North America Point-of-care-testing (Poct) Market, By Region
13.1 North America
13.1.1 U.S.
13.1.2 Canada
13.1.3 Mexico
14 North America Point-of-care Testing (Poct) Market: Company Landscape
14.1 Company Share Analysis: Global
15 Swot Analysis
16 Company Profiles
16.1 Abbott Point Of Care Inc(Abbott)
16.1.1 Company Snapshot
16.1.2 Revenue Analysis
16.1.3 Company Share Analysis
16.1.4 Product Portfolio
16.1.5 Recent Development
16.2 Sinocare.
16.2.1 Company Snapshot
16.2.2 Company Share Analysis
16.2.3 Product Portfolio
16.2.4 Recent Development
16.3 F. Hoffmann-la Roche Ltd
16.3.1 Company Snapshot
16.3.2 Revenue Analysis
16.3.3 Company Share Analysis
16.3.4 Product Portfolio
16.3.5 Recent Development
16.4 Danaher
16.4.1 Company Snapshot
16.4.2 Revenue Analysis
16.4.3 Company Share Analysis
16.4.4 Product Portfolio
16.4.5 Recent Development
16.5 Hologic, Inc
16.5.1 Company Snapshot
16.5.2 Revenue Analysis
16.5.3 Company Share Analysis
16.5.4 Product Portfolio
16.5.5 Recent Development
16.6 Accubiotech Co., Ltd.
16.6.1 Company Snapshot
16.6.2 Product Portfolio
16.6.3 Recent Development
16.7 Abaxis (Abaxis Is A Part Of Zoetis)
16.7.1 Company Snapshot
16.7.2 Product Portfolio
16.7.3 Recent Development
16.8 Autobio
16.8.1 Company Snapshot
16.8.2 Revenue Analysis
16.8.3 Product Portfolio
16.8.4 Recent Development
16.9 Bd Veritor(Bd)
16.9.1 Company Snapshot
16.9.2 Revenue Analysis
16.9.3 Product Portfolio
16.9.4 Recent Development
16.10 Binx Health
16.10.1 Company Snapshot
16.10.2 Solution Portfolio
16.10.3 Recent Development
16.11 Biomerieux
16.11.1 Company Snapshot
16.11.2 Revenue Analysis
16.11.3 Product Portfolio
16.11.4 Recent Development
16.12 Bio- Rad Laboratories, Inc.
16.12.1 Company Snapshot
16.12.2 Revenue Analysis
16.12.3 Product Portfolio
16.12.4 Recent Development
16.13 Chembio Diagnostics, Inc.
16.13.1 Company Snapshot
16.13.2 Product Portfolio
16.13.3 Recent Development
16.14 Ekf Diagnostics Holdings Plc
16.14.1 Company Snapshot
16.14.2 Revenue Analysis
16.14.3 Product Portfolio
16.14.4 Recent Development
16.15 Getein Biotech, Inc.
16.15.1 Company Snapshot
16.15.2 Revenue Analysis
16.15.3 Product Portfolio
16.15.4 Recent Development
16.16 Lamdagen Corporation
16.16.1 Company Snapshot
16.16.2 Product Portfolio
16.16.3 Recent Development
16.17 Meridian Bioscience
16.17.1 Company Snapshot
16.17.2 Product Portfolio
16.17.3 Recent Development
16.18 Nova Biomedical
16.18.1 Company Snapshot
16.18.2 Product Portfolio
16.18.3 Recent Development
16.19 Pfizer Inc.
16.19.1 Company Snapshot
16.19.2 Product Portfolio
16.19.3 Recent Development
16.20 Pts Diagnostics
16.20.1 Company Snapshot
16.20.2 Product Portfolio
16.20.3 Recent Development
16.21 Qiagen
16.21.1 Company Snapshot
16.21.2 Revenue Analysis
16.21.3 Product Portfolio
16.21.4 Recent Development
16.22 Quidelortho Corporation
16.22.1 Company Snapshot
16.22.2 Revenue Analysis
16.22.3 Product Portfolio
16.22.4 Recent Development
16.23 Quantumdx Group Ltd.
16.23.1 Company Snapshot
16.23.2 Product Portfolio
16.23.3 Recent Development
16.24 Sekisui Diagnostics
16.24.1 Company Snapshot
16.24.2 Product Portfolio
16.24.3 Recent. Development
16.25 Shenzhen New Industry Biomedical Engineering Co., Ltd.
16.25.1 Company Snapshot
16.25.2 Revenue Analysis
16.25.3 Product Portfolio
16.25.4 Recent Development
16.26 Siemens Healthineers Ag
16.26.1 Company Snapshot
16.26.2 Revenue Analysis
16.26.3 Product Portfolio
16.26.4 Recent Development
16.27 Sienco, Inc.
16.27.1 Company Snapshot
16.27.2 Product Portfolio
16.27.3 Recent Updates
16.28 Sysmex Corporation
16.28.1 Company Snapshot
16.28.2 Revenue Analysis
16.28.3 Product Portfolio
16.28.4 Recent Development
16.29 Trinity Biotech
16.29.1 Company Snapshot
16.29.2 Revenue Analysis
16.29.3 Pr.Oduct Portfolio
16.29.4 Recent Development
16.30 Trividia Health, Inc.
16.30.1 Company Snapshot
16.30.2 Product Portfolio
16.30.3 Recent Updates
16.31 Thermo Fisher Scientific Inc.
16.31.1 Company Snapshot
16.31.2 Revenue Analysis
16.31.3 Product Portfolio
16.31.4 Recent Development
16.32 Werfen
16.32.1 Company Snapshot
16.32.2 Product Portfolio
16.32.3 Recent Development
16.33 Wondfo
16.33.1 Company Snapshot
16.33.2 Revenue Analysis
16.33.3 Product Portfolio
16.33.4 Recent Development
16.34 Xiamen Boson Biotech Co., Ltd.
16.34.1 Company Snapshot
16.34.2 Product Portfolio
16.34.3 Recent Development
17 Questionnaire
18 Related Reports

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us